←  Go back
Andrew Spellman
Brian Rowen
Liam Patrick
Charlotte Edelman
Kerry Burke
Mara Smith
Katherine Ruf
James Boyd
Bryan Stuart
Kiley Coffey
Alan Swierczynski
Meghan Smith
James Mortimer
Becky D'Amour
Kate Rachesky
Richard Rosenblatt
Constantine Karides
Brent Saunders
Anthony Mulrain
Nick Papapolitis
Tyler Scriven
Robyn Glaser
Dean Dakolias
Brent Saunders

Brent Saunders

Senior Advisor

Brent currently serves as the CEO and Chairman of Bausch + Lomb. Previously, Brent was Chairman, President and CEO of Allergan plc. until the company’s $63 billion acquisition by AbbVie Inc in 2020. Prior to Allergan, Brent was President and CEO and a director of Forest Laboratories Inc., until that company’s $25 billion merger with Actavis plc. in 2014, when he was named CEO of the combined business. Brent then successfully led Actavis’ $66 billion acquisition of Allergan. Brent currently serves as Chairman of the Board of The Beauty Health Company (Nasdaq: SKIN) and as a director of ARS Pharmaceuticals, Inc. (Nasdaq: SPRY). Brent is Chairman of the Board of Roam, a director of Cambrian BioPharma and Fifth Down portfolio company Arena AI, and a Nextech board advisor.